RBC Capital analyst Shagun Singh Chadha maintains $Medtronic (MDT.US)$ with a buy rating, and maintains the target price at $105.
According to TipRanks data, the analyst has a success rate of 46.5% and a total average return of 2.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Medtronic (MDT.US)$'s main analysts recently are as follows:
It's observed that while the HSD EPS growth exit rate for FY25 signals a positive outlook, FY26 poses challenges for the company due to ongoing foreign exchange pressures, the dilutive effect of new product introductions and capital rollouts, and a slight tax disadvantage. These factors are anticipated to restrain a sustainable return to HSD EPS growth.
Medtronic reported a Q2 revenue beat, driven by performance in its cardiovascular, neuro, and diabetes sectors. The company has increased its FY25 guidance to 4.75%-5.0%. Looking ahead to FY26, it is believed that EPS growth could exceed top-line growth.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
